產品中心Cell Resources
聯系我們CONTACT US
400-999-210024小時服務熱線
產品概述
| 名稱 | Caki-1 (人腎透明細胞癌皮膚轉移細胞) (STR鑒定正確) |
| 別稱 | CAKI-1; CaKi-1; caki-1; CAKI.1; CAKI 1; CAKI1; Caki1 |
| 種屬 | 人 |
| 生長特性 | 貼壁細胞 |
| 細胞形態(tài) | 上皮細胞樣 |
| 凍存條件 | 凍存液：55% 基礎培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認） |
生長培養(yǎng)基:
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:2-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 背景描述 | Caki-1細胞的超微結構中包含許多微絨毛、少許微絲、許多小線粒體、充分發(fā)育的高爾基體、內質網、許多脂滴和多層體，次級溶酶體；目前，沒有在Caki-1細胞內發(fā)現病毒顆粒。 |
| 年齡（性別） | 男性；49歲 |
| 組織來源 | 腎透明細胞癌皮膚轉移 |
| 細胞類型 | 腫瘤細胞 |
| 腫瘤類型 | 腎癌細胞 |
| 生物安全等級 | BSL-1 |
| 倍增時間 | ~40-60 hours |
| 致瘤性 | Yes, in nude mice; forms clear cell carcinoma in nude mice consistent with renal primary; also forms tumors in steroid treated hamsters. |
| 抗原表達情況 | Blood Type O; Rh-; HLA A9, B12, Bw35 |
| 保藏機構 | ATCC; HTB-46 DSMZ; ACC-142DSMZ; ACC-731 |
STR鑒定
-
STR位點信息
Amelogenin X CSF1PO 10,11 D2S1338 17,19 D3S1358 17 D5S818 11,12 D7S820 8,12 D8S1179 12,14 D13S317 11,12 D16S539 12 D18S51 14 D19S433 14 D21S11 28,30 FGA 26 PentaD 11,12 PentaE 11,22 TH01 6,8 TPOX 8,11 vWA 15,17 D6S1043 11,12 D12S391 15,17 D2S441 12,14 -
STR鑒定圖
-
參考文獻
-
Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55(2020/12/01)
作者：Jiafu Feng, Yongcan Guo, Yuanmeng Li
期刊：Journal Of Experimental & Clinical Cancer Research
DOI：10.1186/s13046-020-01744-2
影響因子 ：11.300
-
TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3(2024/05/22)
作者：Qi Zhang, Yong Li, Qing Zhu
期刊：Cell Death & Disease
DOI：10.1038/s41419-024-06741-3
影響因子 ：9.000
引用產品：CL-0052
-
Serine hydroxymethyltransferase 2 knockdown induces apoptosis in ccRCC by causing lysosomal membrane permeabilization via metabolic reprogramming(2023/02/20)
作者：Zhangnan Liu, Mengzhen Fan, Junqing Hou
期刊：Cell Death & Disease
DOI：10.1038/s41419-023-05677-4
影響因子 ：9.000
-
Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma(2022/09/30)
作者：Liangmin Fu, Jiahao Bao, Jinhui Li
期刊：Frontiers in Immunology
DOI：10.3389/fimmu.2022.1021935
影響因子 ：8.786
引用產品：CL-0052
-
Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells(2024/03/30)
作者：Ziyao Li, Ye Tian, Huafeng Zong
期刊：APOPTOSIS
DOI：10.1007/s10495-024-01953-6
影響因子 ：7.200
引用產品：CL-0052
-
Selective expansion of renal cancer stem cells using microfluidic single-cell culture arrays for anticancer drug testing(2024/02/01)
作者：Xiaogang Wang, Tao He, Zihe Chen
期刊：LAB ON A CHIP
影響因子 ：6.100
引用產品：CL-0052
-
Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma(2023/08/26)
作者：Yuwei Zhang, Wei Guo, Yangkun Feng
期刊：Computational and Structural Biotechnology Journal
DOI：10.1016/j.csbj.2023.08.023
影響因子 ：6.000
-
LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p(2019/11/21)
作者：Zhuo Ye, Jiachen Duan, Lihui Wang
期刊：Cancer Cell International
影響因子 ：5.800
引用產品：CL-0052
-
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.(2022/09/21)
作者：Longfei Yang, Yuwei Zhang, Yang Wang
期刊：Frontiers in Pharmacology
影響因子 ：5.600
引用產品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910
-
LncRNA-encoded Micropeptide ACLY?-?BP drives lipid deposition and cell proliferation in Clear Cell Renal Cell Carcinoma via maintenance of ACLY acetylation(2023/07/06)
作者：Shenghua Zhang, Zheng Zhang, Xiaolong Liu
期刊：MOLECULAR CANCER RESEARCH
DOI：10.1158/1541-7786.MCR-22-0781
影響因子 ：5.200
-
Spindle pole body component 24 homolog potentiates tumor progression via regulation of SRY-box transcription factor 2 in clear cell renal cell carcinoma(2022/01/14)
作者：Chengfang Sun, Jingchao Wei, Zhilin Long
期刊：Faseb Journal
影響因子 ：4.800
-
TFE3-SLC36A1 axis promotes resistance to glucose starvation in kidney cancer cells(2024/04/08)
作者：Suli Lv, Zongbiao Zhang, Zhenyong Li
期刊：JOURNAL OF BIOLOGICAL CHEMISTRY
影響因子 ：4.800
引用產品：CL-0052
-
Identification of the regulatory mechanism of ACE2 in COVID-19–induced kidney damage with systems genetics approach(2023/03/23)
作者：Xueling Yang, Chunhua Lin, Jian Liu
期刊：JOURNAL OF MOLECULAR MEDICINE-JMM
DOI：10.1007/s00109-023-02304-9
影響因子 ：4.700
引用產品：CL-0052
-
Low ACADM expression predicts poor prognosis and suppressive tumor microenvironment in clear cell renal cell carcinoma(2024/04/25)
作者：Libin Zhou, Min Yin, Fei Guo
期刊：Scientific Reports
DOI：10.1038/s41598-024-59746-5
影響因子 ：4.600
引用產品：CL-0052
-
A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance(2023/04/08)
作者：Longfei Yang, Yuwei Zhang, Yifan Tang
期刊：Scientific Reports
DOI：10.1038/s41598-023-27975-9
影響因子 ：4.600
引用產品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910
-
Upregulation of Metallothionein 1?G (MT1G) Negatively Regulates Ferroptosis in Clear Cell Renal Cell Carcinoma by Reducing Glutathione Consumption(2022/09/27)
作者：Wu Zhang, Min Luo, Bingrui Xiong
期刊：Journal of Oncology
影響因子 ：4.501
引用產品：CL-0052
-
Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients(2024/04/26)
作者：Lei Ren, Jinwen Liu, Qingyuan Lin
期刊：BMC GENOMICS
DOI：10.1186/s12864-024-10307-0
影響因子 ：4.400
引用產品：CL-0052
-
HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma(2021/2/19)
作者：Yuanbo Cui, Chunyan Zhang, Ya Li
期刊：Cell Biology International
影響因子 ：3.900
-
The potential of Lycium barbarum miR166a in kidney cancer treatment(2022/12/28)
作者：Qiang Zhang, Zhiyuan Xie, Yan Li
期刊：EXPERIMENTAL CELL RESEARCH
DOI：10.1016/j.yexcr.2022.113455
影響因子 ：3.700
-
Comprehensive analysis of the HOXA gene family identifes HOXA13as a novel oncogenic gene in kidney renal clear cell carcinoma(2020/05/22)
作者：Yuanbo?Cui, Ming?Yan, Chunyan?Zhang
期刊：JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
DOI：10.1007/s00432-020-03259-x
影響因子 ：3.600
-
Identify CTBP1-DT as an immunological biomarker that promotes lipid synthesis and apoptosis resistance in KIRC(2024/03/21)
作者：Haolin Li, Mintian Fei, Yi Zhang
期刊：GENE
DOI：10.1016/j.gene.2024.148403
影響因子 ：3.500
引用產品：CL-0052
-
P4HA3 promotes clear cell renal cell carcinoma progression via the PI3K/AKT/GSK3β pathway(2023/01/02)
作者：Zhechuan Zhang, Yuanfeng Zhang, Ronggui Zhang
期刊：MEDICAL ONCOLOGY
DOI：10.1007/s12032-022-01926-2
影響因子 ：3.400
-
Sertraline/ICG‐loaded liposome for dual‐modality imaging and effective chemo‐photothermal combination therapy against metastatic clear cell renal cell carcinoma(2020/1/14)
作者：Yuting Lei, Li Zeng, Shuqing Xie
期刊：Chemical Biology & Drug Design
影響因子 ：3.000
引用產品：CL-0052
-
RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma(2023/10/12)
作者：Jing Ma, Shaofei He, Mingyang Li
期刊：PATHOLOGY RESEARCH AND PRACTICE
影響因子 ：2.800
引用產品：CL-0052
-
TTC13 expression and STAT3 activation may form a positive feedback loop to promote ccRCC progression(2023/10/30)
作者：Lingling Xie, Yu Fang, Jianping Chen
期刊：PeerJ
影響因子 ：2.700
引用產品：CL-0052
-
Elevated histone deacetylase 10 expression promotes the progression of clear cell renal cell carcinoma by Notch-1-PTEN signaling axis(2024/05/11)
作者：Bin Zheng, Xue Jiang, Yaqing Liu
期刊：Discover Oncology
DOI：10.1007/s12672-024-01018-9
影響因子 ：2.200
引用產品：CL-0052
-
CircSCNN1A inhibits the proliferation, migration and invasion of renal cell carcinoma cells by decreasing CLDN8 expression through miR-590-5p(2024/05/19)
作者：Tingting Guo, Wanjuan Xiong, Chong Liu
期刊：GENESIS
影響因子 ：1.500
引用產品：CL-0052
FAQs
Q：{{item.question}}
A：
產品資料
識別碼示意圖
